Sanofi India profit decreases 7.45% in (Q4) FY 2020-21

Source

Team Infinities:

Sanofi India Limited NSE Symbol:SANOFI, BSE Security Code:500674 has declared its 4th(fourth) quarter audited standalone financial report from the month of October, 2020 to the month of December, 2020; for the fiscal year 2020-21.

Revenue Reported by Sanofi India Limited for Fourth Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 12 Months Ended (January, 2020 - December, 2020) Corresponding 12 Months Ended (January, 2019 - December, 2019)
736.50 701.50 851.10 2991.70 3164.70
Calculated Revenue of Sanofi India Limited for Fourth Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 12 months Ended(January, 2020 - December, 2020) VS Corresponding 12 months Ended(January, 2019 - December, 2019)
Change Change % Change Change % Change Change %
35.00 4.99%(Revenue Increase) 114.60 13.46%(Revenue Decrease) 173.00 5.47%(Revenue Decrease)

Revenue: Sanofi India Limited's financial report shows that the company's revenue increased by 4.99% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for revenue increase of Rs.35.00 crores, as the company posted revenue of Rs.736.50 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported revenue of Rs.701.50 crores.
The result also shows that the company's revenue decreased by 13.46% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for revenue decrease of Rs.114.60 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted revenue of Rs.851.10 crores.
The company also reported that its revenue decreased by 5.47% in 12 months end(January, 2020 - December, 2020) for revenue decrease of Rs.173.00 crores, since the company reported revenue of Rs.2991.70 crores; in compare to corresponding 12 months end(January, 2019 - December. 2019) when the company posted revenue of Rs.3164.70 crores.

Gross Margin(%) Reported by Sanofi India Limited for Fourth Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 12 Months Ended (January, 2020 - December, 2020) Corresponding 12 Months Ended (January, 2019 - December, 2019)
58.02 55.16 58.21 60.76 56.27
Calculated Gross Margin(%) of Sanofi India Limited for Fourth Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 12 months Ended(January, 2020 - December, 2020) VS Corresponding 12 months Ended(January, 2019 - December, 2019)
Change Change % Change Change % Change Change %
2.86 5.19%(GM Increase) 0.19 0.33%(GM Decrease) 4.49 7.99%(GM Increase)

Gross Margin(%)/ GM: The company's financial report indicates, the company's GM increased by 5.19% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for 2.86% GM increase, as the company reported 58.02% GM; in compare to previous quarter(July, 2020 - September, 2020) when the company reported 55.16% GM.
The result also indicates, the company's GM decreased by 0.33% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for 0.19% GM decrease; in compare to corresponding quarter(October, 2019 - December, 2019) when the company reported 58.21% GM.
The company also reported that its GM increased by 7.99% in 12 months end(January, 2020 - December, 2020) for 4.49% GM increase, since the company reported 60.76% GM; in compare to corresponding 12 months end(January, 2019 - December. 2019) when the company reported 56.27% GM.

EBITDA Reported by Sanofi India Limited for Fourth Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 12 Months Ended (January, 2020 - December, 2020) Corresponding 12 Months Ended (January, 2019 - December, 2019)
191.00 206.90 183.10 761.20 700.10
Calculated EBITDA of Sanofi India Limited for Fourth Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 12 months Ended(January, 2020 - December, 2020) VS Corresponding 12 months Ended(January, 2019 - December, 2019)
Change Change % Change Change % Change Change %
15.90 7.68%(EBITDA Decrease) 7.90 4.31%(EBITDA Increase) 61.10 8.73%(EBITDA Increase)

EBITDA/ Earnings before interest, tax, depreciation and amortization: The company's financial report shows that the company's EBITDA decreased by 7.68% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EBITDA decrease of Rs.15.90 crores, as the company posted EBITDA of Rs.191.00 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EBITDA of Rs.206.90 crores.
The result also shows that the company's EBITDA increased by 4.31% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EBITDA increase of Rs.7.90 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EBITDA of Rs.183.10 crores.
The company also reported that its EBITDA increased by 8.73% in 12 months end(January, 2020 - December, 2020) for EBITDA increase of Rs.61.10 crores, since the company reported EBITDA of Rs.761.20 crores; in compare to corresponding 12 months end(January, 2019 - December. 2019) when the company posted EBITDA of Rs.700.10 crores.

Profit and Loss Reported by Sanofi India Limited for Fourth Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 12 Months Ended (January, 2020 - December, 2020) Corresponding 12 Months Ended (January, 2019 - December, 2019)
123.00(Profit ) 132.90(Profit ) 97.30(Profit ) 477.60(Profit ) 414.20(Profit )
Calculated Profit and Loss of Sanofi India Limited for Fourth Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 12 months Ended(January, 2020 - December, 2020) VS Corresponding 12 months Ended(January, 2019 - December, 2019)
Change Change % Change Change % Change Change %
9.90 7.45%(Profit Decrease) 25.70 26.41%(Profit Increase) 63.40 15.31%(Profit Increase)

Profit and Loss / PAT(Profit after Tax): The company's financial report shows that the company's profit decreased by 7.45% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for profit decrease of Rs.9.90 crores, as the company posted profit of Rs.123.00 crores; in compare to previous quarter(July, 2020 - September, 2020) when the company reported profit of Rs.132.90 crores.
The result also shows that the company's profit increased by 26.41% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for profit increase of Rs.25.70 crores; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted profit of Rs.97.30 crores.
The company also reported that its profit increased by 15.31% in 12 months end(January, 2020 - December, 2020) for profit increase of Rs.63.40 crores, since the company reported profit of Rs.477.60 crores; in compare to corresponding 12 months end(January, 2019 - December. 2019) when the company posted profit of Rs.414.20 crores.

EPS Reported by Sanofi India Limited for Fourth Quarter FY, 2020-21
Current Quarter (October, 2020 - December, 2020) Previous Quarter (July, 2020 - September, 2020) Corresponding Quarter (October, 2019 - December, 2019) 12 Months Ended (January, 2020 - December, 2020) Corresponding 12 Months Ended (January, 2019 - December, 2019)
53.41 57.71 42.26 207.38 179.85
Calculated EPS of Sanofi India Limited for Fourth Quarter FY, 2020-21
Current(December, 2020) VS Previous(September, 2020) Current(December, 2020) VS Corresponding(December, 2019) 12 months Ended(January, 2020 - December, 2020) VS Corresponding 12 months Ended(January, 2019 - December, 2019)
Change Change % Change Change % Change Change %
4.30 7.45%(EPS Decrease) 11.15 26.38%(EPS Increase) 27.53 15.31%(EPS Increase)

EPS /Earning per Share: The company's financial report shows that the company's EPS decreased by 7.45% in QoQ(Quarter on Quarter) / current quarter(October, 2020 - December, 2020) for EPS decrease of Rs.4.30, as the company posted EPS of Rs.53.41; in compare to previous quarter(July, 2020 - September, 2020) when the company reported EPS of Rs.57.71.
The result also shows that the company's EPS increased by 26.38% in YoY(Year over Year) / in current quarter(October, 2020 - December, 2020) for EPS increase of Rs.11.15; in compare to corresponding quarter(October, 2019 - December, 2019) when the company posted EPS of Rs.42.26.
The company also reported that its EPS increased by 15.31% in 12 months end(January, 2020 - December, 2020) for EPS increase of Rs.27.53, since the company reported EPS of Rs.207.38; in compare to corresponding 12 months end(January, 2019 - December. 2019) when the company posted EPS of Rs.179.85.

Assets Reported by Sanofi India Limited for Fourth Quarter FY, 2020-21
Details Non-current Assets Current Assets
Current Year Ended(December, 2020) Previous Year End(December, 2019) Current Year Ended(December, 2020) Previous Year End(December, 2019)
Reported 1085.20 1115.10 1833.30 2129.30
  Change Change % Change Change %
Calculated 29.90 2.68%(Assets Decrease) 296.00 13.90%(Assets Decrease)

Assets:The company reported its non-current assets decreased by 2.68% in current year end(December, 2020) for non-current assets decrease of Rs.29.90 crores, since the company reported net non-current assets of Rs.1085.20 crores; in compare to previous year end(December, 2019) when the company reported net non-current assets of Rs.1115.10 crores.
The balance sheet of the company also shows that, its current assets decreased by 13.90% in current year end(December, 2020) for current assets decrease of Rs.296.00 crores, as the company reported net current assets of Rs.1833.30 crores; against previous year end(December, 2019) when the company reported net current assets of Rs.2129.30 crores.

Liabilities Reported by Sanofi India Limited for Fourth Quarter FY, 2020-21
Details Non-current Liabilities Current Liabilities
Current Year Ended(December, 2020) Previous Year End(December, 2019) Current Year Ended(December, 2020) Previous Year End(December, 2019)
Reported 112.70 98.70 686.80 703.40
  Change Change % Change Change %
Calculated 14.00 14.18%(Liabilities Increase) 16.60 2.36%(Liabilities Decrease)

Liabilities:The company reported its non-current liabilities increased by 14.18% in current year end(December, 2020) for non-current liabilities increase of Rs.14.00 crores, since the company reported net non-current liabilities of Rs.112.70 crores; in compare to previous year end(December, 2019) when the company reported net non-current liabilities of Rs.98.70 crores.
The balance sheet of the company also shows that, its current liabilities decreased by 2.36% in current year end(December, 2020) for current liabilities decrease of Rs.16.60 crores, as the company reported net current liabilities of Rs.686.80 crores; against previous year end(December, 2019) when the company reported net current liabilities of Rs.703.40 crores.

 


***All amounts are given in Crore Indian Rupees(INR) except EPS (Earnings per share) which are in Indian Rupees(INR) only.***
Gross Margin=Total Revenue from Operations -(Cost of Materials Consumed + Purchases of stock-in-trade - Changes in inventories of finished goods, work-in-progress and stock-in-trade).
Gross Margin%=(Gross Margin / Total Revenue from Operations)*100.
EBITDA=Commission/Interest + Depreciation and Amortization + Tax + Profit/Loss (PAT).
1 Lac = 100,000.
1 Million = 10 Lacs.
1 Crore = 10 Millions.
1 Crore = 100 Lacs.
1 Billion = 1000 Millions.
1 Billion = 100 Crores.

 

Add new comment

Comment Editor

  • No HTML tags allowed.